GOLDMAN SACHS GROUP INC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 18 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$23,518,000
-55.8%
1,890,600
-51.4%
0.01%
-64.7%
Q3 2016$53,244,000
+294.8%
3,889,282
+113.1%
0.02%
+325.0%
Q2 2016$13,488,000
+158.6%
1,825,135
+123.7%
0.00%
+300.0%
Q1 2016$5,215,000
+57.8%
816,062
+54.3%
0.00%0.0%
Q4 2015$3,305,000
-25.1%
528,746
-30.0%
0.00%0.0%
Q3 2015$4,412,000
-68.6%
755,326
-55.5%
0.00%
-75.0%
Q2 2015$14,038,000
+5.4%
1,697,478
+5.1%
0.00%0.0%
Q1 2015$13,313,000
-24.5%
1,615,603
-37.1%
0.00%
-20.0%
Q4 2014$17,632,000
+26.6%
2,566,648
-0.5%
0.01%
+25.0%
Q3 2014$13,927,000
+37.8%
2,579,157
+62.5%
0.00%0.0%
Q2 2014$10,108,000
+28.2%
1,586,863
+62.2%
0.00%
+33.3%
Q1 2014$7,887,000
-39.0%
978,465
-48.4%
0.00%
-25.0%
Q4 2013$12,931,000
-91.7%
1,895,946
-77.6%
0.00%
-93.0%
Q3 2013$155,747,000
+28.7%
8,464,530
+22.4%
0.06%
+23.9%
Q2 2013$120,985,000
+165.9%
6,917,370
+191.6%
0.05%
+155.6%
Q4 2012$45,503,000
-19.7%
2,372,395
+1.4%
0.02%
-18.2%
Q3 2012$56,645,000
+142.6%
2,339,775
+72.4%
0.02%
+120.0%
Q2 2012$23,351,000
+177.0%
1,356,848
+157.3%
0.01%
+150.0%
Q1 2012$8,429,000527,4320.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$80,313,00015.61%
Opaleye Management Inc. 1,310,000$8,188,0003.42%
Camber Capital Management LP 5,405,235$33,783,0002.18%
IRONWOOD INVESTMENT MANAGEMENT LLC 471,516$2,947,0001.22%
HighVista Strategies LLC 807,100$5,044,0000.94%
JS Capital Management LLC 630,000$3,938,0000.94%
1492 Capital Management LLC 202,500$1,266,0000.92%
Palo Alto Investors LP 2,257,217$14,108,0000.78%
Geduld E E 185,100$1,157,0000.72%
Elk Creek Partners, LLC 1,592,527$9,953,0000.71%
View complete list of ARIAD PHARMACEUTICALS INC shareholders